---
title: "DC 7123 - Soft tissue sarcoma (of vascular origin)"
diagnostic_code: "7123"
body_system: "Cardiovascular System"
cfr_section: "§ 4.104"
canonical: "https://veteranai.co/va-rating-schedule/cardiovascular/7123-soft-tissue-sarcoma-of-vascular-origin"
source: "https://www.ecfr.gov/current/title-38/section-4.104"
updated: "2026-07-21T04:05:10.325136Z"
---

# DC 7123 - Soft tissue sarcoma (of vascular origin)

Rated under § 4.104. Body system: Cardiovascular System.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Soft tissue sarcoma (of vascular origin) |

## Notes

- Note: A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals.

# Soft Tissue Sarcoma (of Vascular Origin) — VA Disability Rating (Diagnostic Code 7123)

*Cardiovascular System · 38 CFR § 4.104 · Diagnostic Code 7123*

## What This Condition Is

Soft tissue sarcoma of vascular origin is a cancer that arises from the blood vessel tissues of the body. Under the VA rating schedule, it is evaluated within the Cardiovascular System section (§ 4.104) using Diagnostic Code 7123.

## Available Rating Level

The VA provides a single scheduled rating for this condition:

| Rating | Criteria |
|--------|----------|
| **100%** | Soft tissue sarcoma (of vascular origin) |

## What the VA Looks For

The VA applies the following rules when rating this condition:

- **The 100 percent rating continues through treatment.** A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure.

- **A mandatory re-examination follows treatment.** Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by a mandatory VA examination.

- **Changes in evaluation follow a defined process.** Any change in evaluation based upon that examination or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter.

- **Rating after treatment.** If there has been no local recurrence or metastasis, the condition is rated on its residuals.

---

*This information is drawn directly from the VA rating schedule under 38 CFR § 4.104, Diagnostic Code 7123. It is provided for general educational purposes and does not guarantee any specific rating or outcome.*

Source: https://www.ecfr.gov/current/title-38/section-4.104